ALNY Options $198.61 -2.80% (-5.72) unusual options activity for all expirations

Next earnings announcement in 4 days

Unusual Flow By Sentiment

Loading...

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Top Ranked ALNY Unusual Options Activity

(latest unusual options order flow detected by AI)

Bullish Alnylam Pharmaceuticals, Inc. call option contracts are ones that are bought on or above the market's asking price OR put option contracts that are sold on or less than the market's bid price - expecting a move to the upside.
The opposite applies to bearish trades: put options bought on or above the ask OR call options sold at or below the bid price - expecting a move to the downside.



Weighted Average of Option Greeks

Sentiment By Expiry

Order Side Distribution

Loading...

How To Trade ALNY Unusual Options Activity There are many ways to interpret UOA. Some common strategies include looking at the strike prices and comparing them to the current stock price for Alnylam Pharmaceuticals, Inc.. A bullish signal can be intrerpreted if you notice a large amount of contracts traded for strikes that are considered out of the money and expiring in the near future. You can then compare the overall volume for that strike to the open interest at the beginning of the day. A larger volume of option contracts traded compared to the open interest would mean this is a new position that is being opened.


Trade History